Search - tctmd.com

Displaying 261 - 280 of 296

Sort: Relevancy | Date

News Features

Drug-Coated Balloon Approvals Mark ‘Sea Change’ for Treatment of PAD

L.A. McKeown

January 28, 2015

News Industry News

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

September 15, 2014

News Industry News

InspireMD Receives European Regulatory Approval to Resume Manufacturing and Distribution of MGuardTM Prime EPS

June 23, 2014

News Industry News

Abbott to Acquire Veropharm

June 23, 2014

News Industry News

Medtronic CoreValve System Receives FDA Approval for Patients at High Risk for Surgery

June 12, 2014

News Industry News

Medtronic Begins Initial European Market Launch of World's First Combined Glucose Sensor and Insulin Infusion Set for People with Diabetes

June 03, 2014

News Industry News

New study to investigate dabigatran etexilate for prevention of recurrent stroke in high-risk patients

May 07, 2014

News Industry News

New registry data highlight substantial global differences in stroke prevention for patients with an irregular heart beat

May 07, 2014

News Industry News

Boston Scientific Launches Promus PREMIER™ Everolimus-Eluting Platinum Chromium Coronary Stent System In Japan

May 01, 2014

News Daily News

Cardiovascular Devices Make Up Largest Class of FDA Device Recalls Since 2005

Yael L. Maxwell

April 03, 2014

News Industry News

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

March 10, 2014

News Industry News

Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint

January 08, 2014

News Conference News TCT 2013

Regulatory Hurdles Pose Challenges for Device Approvals in US, Europe

October 30, 2013

News Industry News

Boston Scientific Begins Clinical Trial Of Innova™ Peripheral Vascular Drug-Eluting Stent System

October 09, 2013

News Industry News

Boston Scientific Reports Favorable Six-Month Results from Lotus™ Valve System Clinical Trial

September 17, 2013

News Industry News

Boston Scientific Concludes Enrollment In Randomized, Multicenter, Pivotal Study Of SYNERGY™ Coronary Stent System

September 12, 2013

News Industry News

Thoratec Acquires DuraHeart® II Ventricular Assist System

July 01, 2013

News Industry News

Edwards Lifesciences Comments on FDA Warning Letter

May 29, 2013

News Industry News

Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II Trial

May 22, 2013

News Industry News

First Patient Enrolled in the Boston Scientific Multicenter Study of the SYNERGY™ Coronary Stent System Featuring a Bioabsorbable Polymer Coating

November 29, 2012

Advertisement

Drug-Coated Balloon Approvals Mark ‘Sea Change’ for Treatment of PAD

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

InspireMD Receives European Regulatory Approval to Resume Manufacturing and Distribution of MGuardTM Prime EPS

Abbott to Acquire Veropharm

Medtronic CoreValve System Receives FDA Approval for Patients at High Risk for Surgery

Medtronic Begins Initial European Market Launch of World's First Combined Glucose Sensor and Insulin Infusion Set for People with Diabetes

New study to investigate dabigatran etexilate for prevention of recurrent stroke in high-risk patients

New registry data highlight substantial global differences in stroke prevention for patients with an irregular heart beat

Boston Scientific Launches Promus PREMIER™ Everolimus-Eluting Platinum Chromium Coronary Stent System In Japan

Cardiovascular Devices Make Up Largest Class of FDA Device Recalls Since 2005

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint

Regulatory Hurdles Pose Challenges for Device Approvals in US, Europe

Boston Scientific Begins Clinical Trial Of Innova™ Peripheral Vascular Drug-Eluting Stent System

Boston Scientific Reports Favorable Six-Month Results from Lotus™ Valve System Clinical Trial

Boston Scientific Concludes Enrollment In Randomized, Multicenter, Pivotal Study Of SYNERGY™ Coronary Stent System

Thoratec Acquires DuraHeart® II Ventricular Assist System

Edwards Lifesciences Comments on FDA Warning Letter

Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II Trial

First Patient Enrolled in the Boston Scientific Multicenter Study of the SYNERGY™ Coronary Stent System Featuring a Bioabsorbable Polymer Coating

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content